Prospective study of myasthenia gravis in the East Midlands region of the UK

The rising incidence of myasthenia gravis (MG) world-wide has largely been attributed to an increase in cases among older people. Results of a 4-year prospective study show an increased incidence among people over 65 years of age, although the overall incidence remained stable.